checkAd
    Startseite > Aktien > Biomea Fusion > Nachrichten
    Biomea Fusion Aktie
    4,3100
     
    USD
    +4,11 %
    +0,1700 USD
    Letzter Kurs 10.06.24 Nasdaq
    4,2900
     
    USD
    900 STK
    Geldkurs 10.06.24
    4,3000
     
    USD
    400 STK
    Briefkurs 10.06.24
    ISIN: US09077A1060 · WKN: A3CUPH · SYM: BMEA · USA

    Neueste Nachrichten

    Aktien New York Ausblick: Dow nach Arbeitsmarktdaten im Minus erwartet
    07.06.24 · dpa-AFX · Geron (Delaware)
    Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
    06.06.24 · globenewswire · Biomea Fusion
    Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    03.06.24 · globenewswire · Biomea Fusion
    Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes
    30.05.24 · globenewswire · Biomea Fusion
    Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
    02.05.24 · globenewswire · Biomea Fusion
    Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    01.05.24 · globenewswire · Biomea Fusion
    Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    01.04.24 · globenewswire · Biomea Fusion
    Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219
    01.04.24 · globenewswire · Biomea Fusion
    Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
    01.04.24 · globenewswire · Biomea Fusion
    Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle, Supporting Improved Pancreatic Function
    06.03.24 · globenewswire · Biomea Fusion
    Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · Biomea Fusion
    Biomea Fusion Highlights Recent Updates and Anticipated 2024 Corporate Milestones at 42nd Annual J.P. Morgan Healthcare Conference
    09.01.24 · globenewswire · Biomea Fusion